1. Home >
  2. M&A >
  3. Divestiture >
  4. United States >
  5. New Jersey >
  6. H.I.G. Private Equity and Shore Suven Pharma Acquire Rising Pharmaceuticals

M&A Deal Summary

H.I.G. Private Equity and Shore Suven Pharma Acquire Rising Pharmaceuticals

On March 7, 2019, private equity firm H.I.G. Private Equity and Shore Suven Pharma acquired life science company Rising Pharmaceuticals from Actylis for 15M USD

Acquisition Highlights
  • This is H.I.G. Private Equity’s 2nd and Shore Suven Pharma’s 1st transaction in the Life Science sector.
  • This is H.I.G. Private Equity’s 25th and Shore Suven Pharma’s largest (disclosed) transaction.
  • This is H.I.G. Private Equity’s 163rd and Shore Suven Pharma’s 1st transaction in the United States.
  • This is H.I.G. Private Equity’s 4th and Shore Suven Pharma’s 1st transaction in New Jersey.

M&A Deal Summary
Date 2019-03-07
Target Rising Pharmaceuticals
Sector Life Science
Buyer(s) H.I.G. Private Equity
Shore Suven Pharma
Sellers(s) Actylis
Deal Type Divestiture
Deal Value 15M USD

Target

Rising Pharmaceuticals

East Brunswick, New Jersey, United States
Rising Pharmaceuticals is a provider of over the counter pharmaceutical products in the US. Rising Pharmaceuticals was founded in 2002 and is based in East Brunswick, New Jersey.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 2

Buyer

H.I.G. Private Equity

Miami, Florida, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1993
PE ASSETS 65.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

HIG Private Equity is the private equity arm of HIG Capital. The Firm focuses on management buyouts, growth equity investments, and recapitalizations of mid-sized to large companies valued between $50 million and $1 billion. HIG will also consider industry consolidations, going-privates, and corporate divestitures. Sectors of interest include aerospace, building materials, business services, consumer products, distribution, healthcare, infrastructure, contracting, manufacturing, media, oil & gas services, IT, and transportation. HIG was formed in 1993 is based in Miami, Florida.

DEAL STATS #
Overall 241 of 383
Sector: Life Science M&A 2 of 7
Type: Divestiture M&A Deals 28 of 48
State: New Jersey M&A 4 of 7
Country: United States M&A 163 of 249
Year: 2019 M&A 4 of 19
Size (of disclosed) 25 of 25
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-03-05 Synseal Extrusions

Nottinghamshire, United Kingdom

Synseal Extrusions is a UK manufacturer of extruded PVC window and door profiles as well as conservatory roofs. From its integrated, single-site facility near Nottingham, UK, Synseal serves over 700 fabricator customers and is the prime UK consolidator in its industry.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-04-04 Jenny Craig

Carlsbad, California, United States

Jenny Craig is a weight management services company. The Company provides consumers with a comprehensive weight management program that emphasizes personal support to help clients develop a healthy relationship with food, build an active lifestyle, and create a more balanced approach to living. Jenny Craig was founded in 1983 and is based in Carlsbad, California.

Buy -
Buyer

Shore Suven Pharma

United States
Category Company
Sector Life Science
DESCRIPTION

Shore Suven Pharma, Inc. is a joint venture between Suven Life Sciences Limited, an India-based provider of contract research and manufacturing services for the global life sciences industry, and Shore Pharma Investments, LLC, a company founded by Vimal Kavuru to acquire generic drug assets.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: New Jersey M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2019 M&A 1 of 1
Size (of disclosed) 1 of 1

Seller(S) 1

SELLER

Actylis

Port Washington, New York, United States
Category Company
Founded 1947
Sector Chemicals
Revenue 711M USD (2018)
DESCRIPTION

Actylis is a marketer, seller and distributor of products for human health (finished dosage form generics and nutraceutical products), pharmaceutical ingredients (pharmaceutical intermediates and active pharmaceutical ingredients), and performance chemicals (specialty chemicals and agricultural protection products). Actylis was formed in 1947 and is based in Port Washington, New York.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: New Jersey M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2019 M&A 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-11-02 Citron Pharma - Generic Products and Related Assets

East Brunswick, New Jersey, United States

Citron Pharma LLC - Generic Products and Related Assets is a provider of developer of generic products.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-04-17 Syntor Fine Chemicals

Runcorn, United Kingdom

Syntor Fine Chemicals Ltd. develops and supplies fine chemicals for life sciences and other advanced technology end markets. Syntor uses highly sophisticated synthesis and formulation capabilities in a wide range of synthetic organic transformations. Utilizing multi-purpose, ISO-accredited manufacturing facilities, The company provides cost-effective, low-risk production solutions, from early-stage process development through to commercial production. By maintaining an inventory of products in the UK, India, and China, it offers short lead times for exports into key markets globally. Syntor Fine Chemicals was formed in 2004 and is based in Runcorn, United Kingdom.

Buy -
Mergr

Solution for

Product

Company

Legal